Skip to main content
. 2020 Mar 30;9(4):830. doi: 10.3390/cells9040830

Figure 2.

Figure 2

Sorafenib combination in thyroid cancer in preclinical studies. This figure resumes all molecules tested in preclinical studies associated with sorafenib in thyroid cancer and their implications in crucial signaling pathways.